| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 37 |
| 1 | MACITENTAN | 24 |
| 2 | SILDENAFIL CITRATE | 18 |
| 3 | TADALAFIL | 16 |
| 4 | TREPROSTINIL | 16 |
| 5 | AMBRISENTAN | 12 |
| 6 | SILDENAFIL | 12 |
| 7 | 0XYGEN | 9 |
| 8 | OXYGEN | 9 |
| 9 | RIOCIGUAT | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 37 | 0.0037 |
| 1 | OXACILLIN SODIUM | 1 | 0.0013 |
| 2 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0011 |
| 3 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 1 | 0.0009 |
| 4 | MACITENTAN | 24 | 0.0007 |
| 5 | EPOPROSTENOL SODIUM | 4 | 0.0007 |
| 6 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0006 |
| 7 | RIOCIGUAT | 9 | 0.0005 |
| 8 | 0XYGEN | 9 | 0.0004 |
| 9 | OXYGEN | 9 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 50 | 0.0006 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 9 | 0.0005 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 22 | 0.0003 |
| 3 | Endothelin Receptor Antagonist [EPC] | 33 | 0.0002 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0002 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Thiazide-like Diuretic [EPC] | 3 | 0.0001 |
| 7 | Cardiac Glycoside [EPC] | 5 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 7 | 0.0001 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |